Company Filing History:
10 out of 4,770 
1 out of 9 
1 out of 1 Years Active: 1997-2009
Title: Azriel Schmidt: Innovator in Biopharmaceutical Research
Introduction
Azriel Schmidt, an accomplished inventor based in Bryn Mawr, PA, has made significant contributions to the field of biopharmaceuticals. With a remarkable portfolio of 10 patents, Schmidt’s work focuses on innovative approaches to tackle various inflammatory diseases and cancers. His research has positioned him as a key player in the healthcare sector.
Latest Patents
Among Schmidt's latest patents is the invention concerning the Rhesus monkey Nur77 nuclear receptor. This patent details the rhNur77 nuclear receptor and the nucleic acid encoding it. The potential for identifying analytes that can modulate the expression or activity of the rhNur77 nuclear receptor is a critical advancement with implications for treating inflammatory diseases such as osteoarthritis, as well as various bone, neurological, and prostate disorders. Furthermore, the application of rhNur77 extends to combating different types of cancers, including prostate, ovarian, colon, lung, and gastric cancer.
Another significant patent issued to Schmidt involves androgen receptor modulators. This invention describes various compounds that can modulate the androgen receptor in a tissue-selective manner, offering solutions for conditions caused by androgen deficiency. The compounds outlined are useful for treating osteoporosis, male hypogonadism, post-menopausal symptoms, and a variety of cancers. These patents reflect Schmidt's commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Azriel Schmidt has been affiliated with esteemed organizations such as Merck & Company and the Medical College of Pennsylvania. His work in these institutions has provided him with a solid foundation to develop his patented innovations. Schmidt’s research and expertise have had a significant impact on the pharmaceutical field, showcasing his dedication to enhancing healthcare solutions.
Collaborations
Schmidt has collaborated with notable colleagues such as Gideon A. Rodan and Su Jane Rutledge. These partnerships have fostered a collaborative environment that enhances research capabilities and drives innovation in therapeutic development. The expertise of his coworkers has complemented Schmidt's own research, resulting in patents that are beneficial to public health.
Conclusion
In summary, Azriel Schmidt stands out as a prominent inventor whose innovative research in nuclear receptors and androgen receptor modulation continues to pave the way for new treatments. With multiple patents to his name and a rich history of collaboration with leading professionals in the field, Schmidt exemplifies the potential of medical innovation to address critical health challenges. His contributions not only highlight the importance of scientific research but also its profound impact on the future of medicine.